Communities (formerly SIACs) are just one of many member benefits that DIA offers. Each Community provides a discipline-specific, global network where members can share common experiences and knowledge and connect with others in their particular field.
Community Role in DIA. Communities provide a forum for volunteers to network and exchange information. Communities also assist DIA in identifying professional development needs in particular interest areas and in providing information to members in career and professional development, to meet those needs.
Community Leadership. Communities have a chairperson or co-chairpersons who take responsibility for the overall activities of the Community. A core committee facilitates the work of each Community.
DIA ConneX. Community members automatically gain access to DIA ConneX, a trusted, interactive, web-based network that links DIA’s 18,000-member global community.
Already a DIA Member? Login to My DIA to join or manage your Communities and DIA ConneX.
Not a DIA Member? Join today.
Communities include:
Anti-Doping
Chairperson: Ms. Barbara Leishman, F. Hoffmann-La Roche Ltd.
Biotechnology & Innovative Preclinical Sciences
Chairperson: Joy Cavagnaro, Access BIO
Chemistry, Manufacturing & Controls/Quality System
Chairperson: Georges France, Novartis Consumer Health S.A.
Clinical Data Management
Chairperson: Kristin Neff, TARIS Biomedical, Inc.
Clinical Pharmacology
Chairperson: Royce Morrison, Quorum Review, Inc.
Clinical Research
Chairperson: Susan Nunchuck, Actelion Clinical Research
Clinical Safety and Pharmacovigilance
Chairperson: Michael Bui, Bayer Healthcare Pharmaceuticals Inc.
Clinical Trial Disclosure
Chairperson: Robert Paarlberg, Paarlberg & Associates LLC
Devices & Diagnostics
Chairperson: Shayesteh Fuerst-Ladani, SFL Regulatory Affairs and Scientific Communication
Document and Records Management
Chairperson: Lisa Mulcahy, Mulcahy Consulting, LLC
eClinical
Chairperson: Munish Mehra, Global Alliance of Indian Biomedical Professionals
Electronic Regulatory Submissions
Chairperson: Open
Emerging Professionals
Chairperson: Yasmin de Faria Krim, Janssen Pharmaceutical Companies of Johnson & Johnson
Evidence Based Medicine
Chairperson: Open
Global Sourcing
Chairperson: Open
Good Clinical Practices & Quality Assurance
Chairperson: Leslie Sam, Eli Lilly and Company
Information Technology
Chairperson: Pamela Campbell, EMC Corporation
Investigator & Investigative Sites
Chairperson: Ana Marquez, Marquez Clinical Site Partners, LLC
Legal Affairs
Chairperson: Open
Marketing & Sales
Chairperson: Open
Medical Communications
Chairperson: Stacey Fung, Genentech, Inc.
Medical Science Liaison
Chairperson: Rebecca Vermeulen, Genentech
Medical Writing
Chairperson: David Clemow, Eli Lilly and Company
Natural Health Products
Chairperson: Pradip Paul, Strategic Pharmacovigilance and Risk Management Consultant
Patient Engagement Community
Chairperson: Marcia K. Horn, International Cancer Advocacy Network
Pediatric
Chairperson: Gesine Bejeuhr, vfa Research-based Pharmaceutical Companies
Professional Education, Training, & Development
Chairperson: Daniel Mudgett, Medidata Solutions Worldwide
Project Management
Chairperson: John Sun, Novartis Pharmaceuticals Corporation
Quality Risk Management
Chairperson: Peter Schiemann, Widler & Schiemann Ltd
Regulatory Affairs
Chairperson: Sarah Powell, Liquent, Inc.
Statistics
Chairperson: Joan Buenconsejo, FDA
Study Endpoints
Chairperson: Keith Wenzel, Perceptive Informatics
Translational Medicine
Chairperson: Aamir Shahzad, European Society For Translational Medicine (EUSTM)
Validation
Chairperson: Richard Chamberlain, Executive Consultant Services